Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial.

ABSTRACT:

Objectives

Data on costs associated with acute upper gastrointestinal bleeding (AUGIB) are scarce. We provide estimates of UK healthcare costs, indirect costs and health-related quality of life (HRQoL) for patients presenting to hospital with AUGIB.

Setting

Six UK university hospitals with >20 AUGIB admissions per month, >400 adult beds, 24 h endoscopy, and on-site access to intensive care and surgery.

Participants

936 patients aged ≥18 years, admitted with AUGIB, and enrolled between August 2012 and March 2013 in the TRIGGER trial of AUGIB comparing restrictive versus liberal red blood cell (RBC) transfusion thresholds.

Primary and secondary outcome measures

Healthcare resource use during hospitalisation and postdischarge up to 28  days, unpaid informal care,

SUBMITTER: Campbell HE 

PROVIDER: S-EPMC4420945 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature